Your browser doesn't support javascript.
loading
A study protocol for a randomised open-label clinical trial of artesunate-mefloquine versus chloroquine in patients with non-severe Plasmodium knowlesi malaria in Sabah, Malaysia (ACT KNOW trial).
Grigg, M J; William, T; Dhanaraj, P; Menon, J; Barber, B E; von Seidlein, L; Rajahram, G; Price, R N; Anstey, N M; Yeo, T W.
Afiliación
  • Grigg MJ; Global Health and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia Infectious Diseases Society Sabah-Menzies School of Health Research Clinical Research Unit, KotaKinabalu, Sabah, Malaysia.
  • William T; Infectious Diseases Society Sabah-Menzies School of Health Research Clinical Research Unit, KotaKinabalu, Sabah, Malaysia Infectious Diseases Unit, Clinical Research Centre, Queen Elizabeth Hospital, KotaKinabalu, Sabah, Malaysia Sabah Department of Health, KotaKinabalu, Sabah, Malaysia.
  • Dhanaraj P; Sabah Department of Health, KotaKinabalu, Sabah, Malaysia Kudat District Hospital, Kudat, Sabah, Malaysia.
  • Menon J; Sabah Department of Health, KotaKinabalu, Sabah, Malaysia.
  • Barber BE; Global Health and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia Infectious Diseases Society Sabah-Menzies School of Health Research Clinical Research Unit, KotaKinabalu, Sabah, Malaysia.
  • von Seidlein L; Global Health and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia Mahidol-Oxford Research Unit, Bangkok, Thailand.
  • Rajahram G; Infectious Diseases Society Sabah-Menzies School of Health Research Clinical Research Unit, KotaKinabalu, Sabah, Malaysia Infectious Diseases Unit, Clinical Research Centre, Queen Elizabeth Hospital, KotaKinabalu, Sabah, Malaysia.
  • Price RN; Global Health and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia Nuffield Department of Clinical Medicine, Centre for Tropical Medicine, University of Oxford, Oxford, UK.
  • Anstey NM; Global Health and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia Infectious Diseases Society Sabah-Menzies School of Health Research Clinical Research Unit, KotaKinabalu, Sabah, Malaysia Division of Medicine, Royal Dar
  • Yeo TW; Global Health and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia Infectious Diseases Society Sabah-Menzies School of Health Research Clinical Research Unit, KotaKinabalu, Sabah, Malaysia Lee Kong Chian School of Medici
BMJ Open ; 4(8): e006005, 2014 Aug 19.
Article en En | MEDLINE | ID: mdl-25138814
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Mefloquina / Cloroquina / Plasmodium knowlesi / Artemisininas / Malaria / Antimaláricos Tipo de estudio: Clinical_trials / Guideline País/Región como asunto: Asia Idioma: En Revista: BMJ Open Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Mefloquina / Cloroquina / Plasmodium knowlesi / Artemisininas / Malaria / Antimaláricos Tipo de estudio: Clinical_trials / Guideline País/Región como asunto: Asia Idioma: En Revista: BMJ Open Año: 2014 Tipo del documento: Article